References
- Planas R, Montoliu S, Ballesté B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–1394.
- Guevara M, Cárdenas A, Uriz J, et al. Prognosis in patients with cirrhosis and ascites. In: Ginès P, Arroyo V, Rodés J, et al., editors. Ascites and renal dysfunction in liver disease: pathogenesis, diagnosis and treatment. Malden: Blackwell; 2005. p. 260–270.
- Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004;40:802–810.
- Gines P, Angeli P, lenz K, et al. Clinical Practice Guidelines EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis Clinical Practice Guidelines. J Hepatol. 2010;53:397–417.
- Albillos A, Lario M, Àlvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385–1396.
- Garred P, Genster N, Pilely K, et al. A journey through the lectin pathway of complement-MBL and beyond. Immunol Rev. 2016;274:74–97.
- Nagura H, Hasegawa H, Yoshimura S, et al. The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis. Acta Pathol Jpn. 1985;35:71–78.
- Altorjay I, Vitalis Z, Tornai I, et al. Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. J Hepatol. 2010;53:484–491.
- Arvaniti V, D’Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010;139:1246–1256.
- Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
- Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805.
- Munthe-Fog L, Hummelshøj T, Hansen BE, et al. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol. 2007;65:383–392.
- Munthe-Fog L, Hummelshøj T, Ma YJ, et al. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol. 2008;45:2660–2666.
- Munthe-Fog L, Hummelshoj T, Honoré C, et al. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun. 2012;13:515–522.
- Garred P, Madsen HO, Kurtzhals JA, et al. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet. 1992;19:403–412.
- Kocbek V, Vouk K, Bersinger NA, et al. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis. J Mol Diagnostics. 2015;17:325–334.
- Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology. 1988;8:632–635.
- Runyon BA, Morrissey RL, Hoefs JC, et al. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology. 1985;5:634–637.
- Such J, Guarner C, Enriquez J, et al. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol. 1988;6:80–84.
- Mustafa G, Khan M, Alam K, et al. Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without spontaneous bacterial peritonitis. Hepatogastroenterology. 2007;54:1905–1907.
- Mal F, Huu TP, Bendahou M, et al. Chemoattractant and opsonic activity in ascitic fluid: a study in 47 patients with cirrhosis or malignant peritonitis. J Hepatol. 1991;12:45–49.
- Foldi I, Tornai T, Tornai D, et al. Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. Liver Int. 2017;37:1023–1031.
- Laursen TL, Sandahl TD, Støy S, et al. Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int. 2015;35:756–763.
- Homann C, Varming K, Mollnes TE, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut. 1997;40:544–549.